The global capsule endoscopy system market size was USD 565.4 Mn in 2022 and is likely to reach USD 1080.53 Mn by 2031, expanding at a CAGR of 9.9% during 2023 – 2031. The growth of the market is attributed to the increasing demand for capsule endoscopy systems for the diagnosis and treatment of digestive tract diseases.
Capsule endoscopy is a diagnostic procedure that involves the use of a miniature wireless camera to capture images of the digestive tract. The camera is enclosed within a small capsule that patients can swallow. The capsule also contains a light source and a transmitter to relay the captured images to an external recorder that the patient wears during the procedures.
As the capsule endoscopy travels through the digestive tract, it captures thousands of images which are transmitted wirelessly to the external recorders. These recorded images are then stored for later evaluation by medical professionals. The capsule endoscopy procedure offers several benefits as a diagnostic tool for the examination of the digestive tract.
This procedure is a minimally invasive alternative to traditional endoscopy and allows for visualization of areas of the digestive tract that may not be accessible with other diagnostic tools. It provides high-quality images of the small intestine. Capsule endoscopy technology is a safe and well-tolerated procedure that eliminates the need for sedation. The wireless nature of the device allows patients to continue their daily activities during the procedures.
The COVID-19 pandemic moderately impacted the capsule endoscopy system market. The disruption of supply chains, manufacturing operations, and logistics has slowed down the production and distribution of these systems. Moreover, the primary focus of healthcare providers had shifted to COVID-19 patients, which affected the market. On the other hand, the need for non-invasive diagnostic tools that reduces patient contact and minimize the risk of infection has increased, which boosted the market to a certain limit.
Capsule Endoscopy System Market Dynamics
Major Drivers
- Increasing awareness regarding the availability of painless and minimally invasive visualization techniques for diagnosing is expected to drive the market. Video capsule endoscopy (VCE) offers accurate diagnostics for various disorders including cancer, inflammatory bowel disorders, and others. This technique involves the use of a wireless capsule that captures and transmits high-quality images of the digestive tract on an external recorder for analysis. Growing demand for minimally invasive surgery accelerates the market.
- Rising incidence of gastrointestinal illnesses such as Crohn’s disease, appendicitis, and colorectal cancers are likely to boost the market. The wireless capsule endoscopy technique captures high-quality images of the digestive tract that enables healthcare professionals to easily identify potential issues and recommends appropriate treatments.
Existing Restraints
- The high risk of capsule retention inside the body during the clinical capsule endoscopy (CCE) procedure is expected to hinder the market. Capsules can get stuck in the digestive tract, which may create complications for patients. Obstruction of the digestive tract causes pain and discomfort and potentially requires a surgical invention to remove the devices.
Emerging Opportunities
- Increasing research activities and the development of advanced imaging technologies are likely to create favorable opportunities for the key players competing in the endoscopy device market. The utilization of high-resolution cameras and lighting technology advancements has facilitated superior visualization that detects abnormalities and enables accurate diagnosis for appropriate treatments. Furthermore, the implementation of artificial intelligence and machine learning algorithms allows to analyze the voluminous data generated by wireless capsule endoscopy devices.
Scope of the Capsule Endoscopy System Market Report
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Capsule Endoscopy System Market- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Product (Oesophageal, Bowel, and Colon), Application (Obscure Gastrointestinal Bleeding, Crohn’s Disease, Small Intestine Tumor, and Others), and End User (Hospitals, Ambulatory Surgery Centers, Laboratories, Specialty Clinics, And Others).
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
AnX Robotics.; Boston Scientific Corporation; CapsoCam Plus; Check-Cap.; FUJIFILM Corporation; INTROMEDIC; JINSHAN Science & Technology (Group) Co., Ltd.; Medtronic; Olympus Corporation; RF Co.,Ltd.; Smart Medical Systems Ltd.; Tracxn Technologies Limited.
|
Capsule Endoscopy System Market Segment Insights
Based on the product, the capsule endoscopy system market is divided into oesophageal, bowel, and colon. The bowel segment is expected to hold a major revenue share of the market during the forecast period, owing to the increasing prevalence of gastrointestinal disorders including inflammatory bowel disease (IBD) and colon cancer among the elder population.
Bowel capsule endoscopy enables non-invasive visualization of the small intestine, which allows early detection of lesions and tumors for facilitating timely interventions. Moreover, this endoscopy system offers serval benefits over traditional endoscopy procedures such as reduced discomfort and faster recovery time. It has the ability to examine the entire digestive tract. It also eliminates the need for sedation and anesthesia drug and reduces the risk of adverse reactions.
In terms of application, the market is fragmented into obscure gastrointestinal bleeding, crohn’s disease, small intestine tumors, and others. The obscure gastrointestinal bleeding [OGIB] segment is expected to register a robust growth rate during the projected period, due to the rising requirement for the treatment of gastrointestinal bleeding. Gastrointestinal bleeding caused due to unhealthy lifestyle habits including high consumption of processed foods, smoking, and excessive alcohol consumption. The use of capsule endoscopy equipment allows accurate diagnosis and treat bleeding in the digestive tract, which is often difficult to detect through traditional endoscopy procedures.
On the basis of end-user, the capsule endoscopy system market is segregated into hospitals, ambulatory surgery centers, laboratories, specialty clinics, and others. The hospitals segment is anticipated to dominate the market in the coming years, owing to the growing number of screenings performed in the hospitals due to the wide availability of trained medical professionals. The hospitals offer greater accessibility for patients to undergo this medical procedure. Furthermore, the various factor such as improved emergency services and the availability of treatment at an affordable cost in government hospitals are likely to boost the segment.
The ambulatory surgery centers segment is anticipated to expand at a high CAGR in the coming years, as it offers several benefits including a reduction in overnight hospital stays, cost-effectiveness, and convenience. It offers a more comfortable and less intimidating environment for patients than hospitals during the procedure. The ease of accessibility for patients during the emergency situation is likely to fuel the segment.
Regional Outlook
In terms of region, the global endoscopy system market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to the presence of well-established healthcare infrastructures and a high adoption rate of advanced medical technologies. This has led to the increasing awareness and acceptance of the capsule endoscopy system among healthcare professionals and patients. The increasing adoption of outpatient procedures and same-day surgeries in North America has made capsule endoscopy a convenient option for patients.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, owing to the increasing prevalence of gastrointestinal diseases and disorders in this region. The changing lifestyles and dietary habits are contributing to the rise in gastrointestinal disorders such as inflammatory bowel disease, colorectal cancer, and Crohn’s disease. Furthermore, rising government funding for upgrading healthcare facilities and the rising demand for inflammatory bowel disease treatment are expected to boost the regional market.
Segments
The global capsule endoscopy system market has been segmented on the basis of
Product
- Oesophageal
- Small Bowel
- Colon
Application
- Obscure Gastrointestinal Bleeding
- Crohn’s Disease
- Small Intestine Tumour
- Others
End User
- Hospitals
- Diagnostic
- Laboratories
- Specialty Clinics
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- AnX Robotics.
- Boston Scientific Corporation
- CapsoCam Plus
- Check-Cap.
- FUJIFILM Corporation
- INTROMEDIC
- JINSHAN Science & Technology (Group) Co., Ltd.
- Medtronic
- Olympus Corporation
- RF Co.,Ltd.
- Smart Medical Systems Ltd.
- Tracxn Technologies Limited.
Competitive Landscape
Key players in the global capsule endoscopy system market are AnX Robotics.; Boston Scientific Corporation; CapsoCam Plus; Check-Cap.; FUJIFILM Corporation; INTROMEDIC; JINSHAN Science & Technology (Group) Co., Ltd.; Medtronic; Olympus Corporation; RF Co.,Ltd.; Smart Medical Systems Ltd.; and Tracxn Technologies Limited.
These companies adopted various strategies such as partnerships, mergers, new product launches, and collaboration to increase their share. For instance,
- In September 2022, Sony Corporation, Sony Olympus medical solution, and Olympus Corporation, a joint venture of Sony and Olympus developed a surgical endoscopy visualization system. The system offers surgical visualization with advanced features including NBI (Narrow Band Imaging) and infrared (IR) imaging.